Number of SEER-MHOS (1998-2023) Respondents (Age 65+) by First Cancer Site
Printable Version (XLSX, 14 KB)
| First Cancer (#) | Number of linked Patients with One or More survey (Group A) |
More than one survey* (Subset of Group A) |
Survey before Cancer Diagnosis (Group B) |
Survey both before and after Cancer Diagnosis** (Subset of Group B) |
Survey after Cancer Diagnosis (Group C) |
||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | N | % | N | % | ||
| Prostate (28010) | 75,148 | 36,156 | (48.11) | 25,888 | (34.45) | 5,740 | (7.64) | 54,989 | (73.17) |
| Breast (26000) | 69,352 | 34,577 | (49.86) | 25,640 | (36.97) | 5,304 | (7.65) | 49,002 | (70.66) |
| Colorectal (21041-21052) | 39,948 | 18,863 | (47.22) | 19,364 | (48.47) | 2,906 | (7.27) | 23,487 | (58.79) |
| Lung and bronchus (22030) | 39,297 | 16,815 | (42.79) | 31,491 | (80.14) | 2,358 | (6.00) | 10,155 | (25.84) |
| Ovary (27040) | 3,904 | 1,805 | (46.23) | 2,393 | (61.3) | 234 | (5.99) | 1,745 | (44.7) |
| Uterus (27020, 27030) | 12,483 | 6,041 | (48.39) | 4,544 | (36.4) | 800 | (6.41) | 8,737 | (69.99) |
| Cervix (27010) | 1,699 | 741 | (43.61) | 551 | (32.43) | 61 | (3.59) | 1,209 | (71.16) |
| Bladder (29010) | 20,179 | 9,865 | (48.89) | 10,963 | (54.33) | 1,732 | (8.58) | 10,948 | (54.25) |
| Melanomas - skin (25010) | 21,551 | 11,345 | (52.64) | 10,041 | (46.59) | 1,876 | (8.70) | 13,333 | (61.87) |
| Head and Neck (20010-20100,22010,22020) | 9,885 | 4,471 | (45.23) | 4,848 | (49.04) | 699 | (7.07) | 5,736 | (58.03) |
| Kidney and Renal pelvis (29020) | 10,543 | 4,933 | (46.79) | 5,566 | (52.79) | 873 | (8.28) | 5,849 | (55.48) |
| Non-Hodgkin’s lymphomas - nodal & extranodal (33041,33042) | 13,994 | 6,741 | (48.17) | 8,229 | (58.8) | 1,065 | (7.61) | 6,828 | (48.79) |
| Stomach (21020) | 5,064 | 2,162 | (42.69) | 3,657 | (72.22) | 286 | (5.65) | 1,692 | (33.41) |
| Pancreas (21100) | 8,079 | 3,471 | (42.96) | 7,407 | (91.68) | 267 | (3.3) | 939 | (11.62) |
* At least one survey must be two years after first survey.
** Number of individuals with a survey before their first cancer diagnosis and also a survey after their first cancer diagnosis.
Note:
- The denominator for the percentages that appear in columns 3 through 6 is the Number of linked patients with one or more survey by cancer site (column 2).
- The groups in columns 4 through 6 are not mutually exclusive, therefore, the percentages do not sum to 100.
